Interna Therapeutics Collaborates with Daiichi Sankyo on MNM-Based Delivery Technology
Interna Therapeutics has announced a research collaboration with Daiichi Sankyo to advance its Molecular Nano Motor (MNM) intracellular delivery platform. The partnership aims to enhance targeted therapeutic delivery and improve therapeutic performance. This collaboration highlights growing interest in Interna's technology from major pharmaceutical companies.
Topics: biotechnology Daiichi Sankyo drug delivery MNM platform research collaboration